A. Goy Et Al. , "RANDOMIZED PHASE II TRIAL COMPARING OBINUTUZUMAB (GA101) WITH RITUXIMAB IN PATIENTS WITH RELAPSED CD20+INDOLENT B-CELL NON-HODGKIN LYMPHOMA: PRELIMINARY ANALYSIS OF THE GAUSS STUDY," HAEMATOLOGICA , vol.97, pp.322-323, 2012
Goy, A. Et Al. 2012. RANDOMIZED PHASE II TRIAL COMPARING OBINUTUZUMAB (GA101) WITH RITUXIMAB IN PATIENTS WITH RELAPSED CD20+INDOLENT B-CELL NON-HODGKIN LYMPHOMA: PRELIMINARY ANALYSIS OF THE GAUSS STUDY. HAEMATOLOGICA , vol.97 , 322-323.
Goy, A., Offner, F., Martinelli, G., Caballero, D., Gadeberg, O., Gaidano, G., ... Press, O.(2012). RANDOMIZED PHASE II TRIAL COMPARING OBINUTUZUMAB (GA101) WITH RITUXIMAB IN PATIENTS WITH RELAPSED CD20+INDOLENT B-CELL NON-HODGKIN LYMPHOMA: PRELIMINARY ANALYSIS OF THE GAUSS STUDY. HAEMATOLOGICA , vol.97, 322-323.
Goy, A. Et Al. "RANDOMIZED PHASE II TRIAL COMPARING OBINUTUZUMAB (GA101) WITH RITUXIMAB IN PATIENTS WITH RELAPSED CD20+INDOLENT B-CELL NON-HODGKIN LYMPHOMA: PRELIMINARY ANALYSIS OF THE GAUSS STUDY," HAEMATOLOGICA , vol.97, 322-323, 2012
Goy, A. Et Al. "RANDOMIZED PHASE II TRIAL COMPARING OBINUTUZUMAB (GA101) WITH RITUXIMAB IN PATIENTS WITH RELAPSED CD20+INDOLENT B-CELL NON-HODGKIN LYMPHOMA: PRELIMINARY ANALYSIS OF THE GAUSS STUDY." HAEMATOLOGICA , vol.97, pp.322-323, 2012
Goy, A. Et Al. (2012) . "RANDOMIZED PHASE II TRIAL COMPARING OBINUTUZUMAB (GA101) WITH RITUXIMAB IN PATIENTS WITH RELAPSED CD20+INDOLENT B-CELL NON-HODGKIN LYMPHOMA: PRELIMINARY ANALYSIS OF THE GAUSS STUDY." HAEMATOLOGICA , vol.97, pp.322-323.
@article{article, author={A. Goy Et Al. }, title={RANDOMIZED PHASE II TRIAL COMPARING OBINUTUZUMAB (GA101) WITH RITUXIMAB IN PATIENTS WITH RELAPSED CD20+INDOLENT B-CELL NON-HODGKIN LYMPHOMA: PRELIMINARY ANALYSIS OF THE GAUSS STUDY}, journal={HAEMATOLOGICA}, year=2012, pages={322-323} }